Доступ предоставлен для: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems
Главный редактор: Mandip Sachdeva Singh (open in a new tab)

Выходит 6 номеров в год

ISSN Печать: 0743-4863

ISSN Онлайн: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications

Том 35, Выпуск 6, 2018, pp. 555-588
DOI: 10.1615/CritRevTherDrugCarrierSyst.2018024751
Get accessGet access

Краткое описание

Some of the criteria for selection of a viable nanocarrier formulation currently being explored are the development of a site-specific and bioavailable formulation. Although the literature reports a variety of techniques for fabrication of nanocarrier systems, their stability and scale-up issues are a concern for their prominence in the pharmaceutical industry. The other widely recognized drawbacks of nanoparticulates, i.e., polymeric nanoparticles and lipid vesicular nanoparticles (liposomes), are low circulatory half-lives due to reticuloendothelial system (RES) uptake and leaky architecture leading to burst kinetics. Polymeric lipid hybrid nanoparticles (PLHNs) or lipomers are the recent advancement in nanodrug delivery systems composed of a polymeric core and lipid shell which imparts physicochemical stability and biocompatibility to the nanoparticles. The lipomers are a blend of positive attributes of both liposomes and polymeric nanoparticles wherein their individual innate flaws are negated. An extensive study of PLHN was engineered using single/two or multiple methods carried out for encapsulation efficiency, physicochemical properties, and stability. The influence of shape and composition of PLHN has also shown promising results in terms of reticuloendothelial uptake. These PLHNs have shown to hold a promising place in designing drug delivery systems for the treatment of cancer and infectious diseases as well as for theranostic purposes. The present review article encompasses various types of PLHNs, their physicochemical characteristics, and their applications as future perspectives in strategizing drug delivery to their desired sites of action.

Ключевые слова: polymeric lipid hybrid, nanobins, nanoparticles, lipomers
ЦИТИРОВАНО В
  1. Yang Hobin, Le Quoc-Viet, Shim Gayong, Oh Yu-Kyoung, Shin Young Kee, Molecular engineering of antibodies for site-specific conjugation to lipid polydopamine hybrid nanoparticles, Acta Pharmaceutica Sinica B, 10, 11, 2020. Crossref

  2. Yadav Krishna, Soni Akanksha, Singh Deependra, Singh Manju Rawat, Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies, Progress in Biomaterials, 10, 1, 2021. Crossref

  3. Ghitman Jana, Biru Elena Iuliana, Stan Raluca, Iovu Horia, Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine, Materials & Design, 193, 2020. Crossref

  4. Wilhelm Romero Krissia, Quirós María Isabel, Vargas Huertas Felipe, Vega-Baudrit José Roberto, Navarro-Hoyos Mirtha, Araya-Sibaja Andrea Mariela, Design of Hybrid Polymeric-Lipid Nanoparticles Using Curcumin as a Model: Preparation, Characterization, and In Vitro Evaluation of Demethoxycurcumin and Bisdemethoxycurcumin-Loaded Nanoparticles, Polymers, 13, 23, 2021. Crossref

  5. Anwer Md. Khalid, Ali Essam A., Iqbal Muzaffar, Ahmed Mohammed Muqtader, Aldawsari Mohammed F., Saqr Ahmed Al, Ansari Mohd Nazam, Aboudzadeh M. Ali, Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability, Molecules, 27, 1, 2021. Crossref

  6. Sivadasan Durgaramani, Sultan Muhammad Hadi, Madkhali Osama, Almoshari Yosif, Thangavel Neelaveni, Polymeric Lipid Hybrid Nanoparticles (PLNs) as Emerging Drug Delivery Platform—A Comprehensive Review of Their Properties, Preparation Methods, and Therapeutic Applications, Pharmaceutics, 13, 8, 2021. Crossref

  7. Kamali Hossein, Nosrati Rahim, Malaekeh-Nikouei Bizhan, Nanostructures and their associated challenges for drug delivery, in Hybrid Nanomaterials for Drug Delivery, 2022. Crossref

  8. Rout Smruti Rekha, Gowtham Kenguva, Sheikh Afsana, Parvez Suhel, Dandela Rambabu, Kesharwani Prashant, Recent advances and future prospective of hybrid drug delivery systems, in Hybrid Nanomaterials for Drug Delivery, 2022. Crossref

  9. Shah Saurabh, Famta Paras, Raghuvanshi Rajeev Singh, Singh Shashi Bala, Srivastava Saurabh, Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications, Colloid and Interface Science Communications, 46, 2022. Crossref

  10. Kazmi Imran, Al-Abbasi Fahad A., Imam Syed Sarim, Afzal Muhammad, Nadeem Muhammad Shahid, Altayb Hisham N., Alshehri Sultan, Formulation and Evaluation of Apigenin-Loaded Hybrid Nanoparticles, Pharmaceutics, 14, 4, 2022. Crossref

  11. Moghaddam Faezeh Abbaspour, Ebrahimian Mahboubeh, Oroojalian Fatemeh, Yazdian-Robati Rezvan, Kalalinia Fatemeh, Tayebi Lobat, Hashemi Maryam, Effect of thymoquinone-loaded lipid–polymer nanoparticles as an oral delivery system on anticancer efficiency of doxorubicin, Journal of Nanostructure in Chemistry, 12, 1, 2022. Crossref

  12. Conte Gemma, Costabile Gabriella, Baldassi Domizia, Rondelli Valeria, Bassi Rosaria, Colombo Diego, Linardos Giulia, Fiscarelli Ersilia V., Sorrentino Raffaella, Miro Agnese, Quaglia Fabiana, Brocca Paola, d’Angelo Ivana, Merkel Olivia M., Ungaro Francesca, Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?, ACS Applied Materials & Interfaces, 14, 6, 2022. Crossref

  13. Persano Francesca, Gigli Giuseppe, Leporatti Stefano, Lipid-polymer hybrid nanoparticles in cancer therapy: current overview and future directions, Nano Express, 2, 1, 2021. Crossref

  14. Singh Bhupinder, Sharma Teenu, Kaur Ranjot, Saini Sumant, Kaur Ripandeep, Beg Sarwar, QbD-Steered Systematic Development of Drug Delivery Nanoconstructs: Vital Precepts, Retrospect and Prospects, in Biomedical Translational Research, 2022. Crossref

  15. Tang Menghuan, Lin Kai, Ramachandran Mythili, Li Longmeng, Zou Hongye, Zheng Huzhi, Ma Zhao, Li Yuanpei, A mitochondria-targeting lipid–small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model, Acta Pharmaceutica Sinica B, 12, 6, 2022. Crossref

  16. Quintanar‐Guerrero David, Leyva‐Gómez Gerardo, Vergara Nancy Evelyn Magaña, Muñoz Néstor Mendoza, Nanopharmaceuticals, in Nanomaterials and Nanotechnology in Medicine, 2022. Crossref

  17. Visakh P. M., Nanomaterials and Nanotechnology in Medicine, in Nanomaterials and Nanotechnology in Medicine, 2022. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain